Search

Your search keyword '"Khuwaja, Salma"' showing total 119 results
Start Over Author "Khuwaja, Salma"
119 results on '"Khuwaja, Salma"'

2. Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas

Author

Lee, Francis, Khanna, Aditya S, Hallmark, Camden J, Lavingia, Richa, McNeese, Marlene, Zhao, Jing, McNeese, Melanie L, Khuwaja, Salma, Ardestani, Babak M, Collier, Nicholson, Ozik, Jonathan, Hotton, Anna L, Harawa, Nina T, Schneider, John A, and Fujimoto, Kayo

Subjects
Applied Economics, Economics, Health Services and Systems, Health Sciences, Human Society, Policy and Administration, Sexual and Gender Minorities (SGM/LGBT*), Infectious Diseases, Prevention, HIV/AIDS, Health Disparities, Sexually Transmitted Infections, Infection, Good Health and Well Being, Humans, Male, HIV, HIV Infections, Homosexuality, Male, Sexual and Gender Minorities, Texas, pre-exposure prophylaxis, computer simulation, data mining, sexual and gender minorities, preventive medicine, Public Health and Health Services, Health Policy & Services, Applied economics, Health services and systems, Policy and administration
Abstract

ContextMedicaid expansion has been nationally shown to improve engagement in the human immunodeficiency virus (HIV) treatment and prevention continua, which are vital steps to stopping the HIV epidemic. New HIV infections in the United States are disproportionately concentrated among young Black men who have sex with men (YBMSM). Houston, TX, is the most populous city in the Southern United States with a racially/ethnically diverse population that is located in 1 of 11 US states that have not yet expanded Medicaid coverage as of 2021.MethodsAn agent-based model that incorporated the sexual networks of YBMSM was used to simulate improved antiretroviral treatment and pre-exposure prophylaxis (PrEP) engagement through Medicaid expansion in Houston, TX. Analyses considered the HIV incidence (number of new infections and as a rate metric) among YBMSM over the next 10 years under Medicaid expansion as the primary outcome. Additional scenarios, involving viral suppression and PrEP uptake above the projected levels achieved under Medicaid expansion, were also simulated.ResultsThe baseline model projected an HIV incidence rate of 4.96 per 100 person years (py) and about 368 new annual HIV infections in the 10th year. Improved HIV treatment and prevention continua engagement under Medicaid expansion resulted in a 14.9% decline in the number of annual new HIV infections in the 10th year. Increasing viral suppression by an additional 15% and PrEP uptake by 30% resulted in a 44.0% decline in new HIV infections in the 10th year, and a 27.1% decline in cumulative infections across the 10 years of the simulated intervention.FindingsSimulation results indicate that Medicaid expansion has the potential to reduce HIV incidence among YBMSM in Houston. Achieving HIV elimination objectives, however, might require additional effective measures to increase antiretroviral treatment and PrEP uptake beyond the projected improvements under expanded Medicaid.

Published
2023

3. Outcomes up to age 36 months after congenital Zika virus infection—U.S. states

Author

Neelam, Varsha, Woodworth, Kate R., Chang, Daniel J., Roth, Nicole M., Reynolds, Megan R., Akosa, Amanda, Carr, Christopher P., Anderson, Kayla N., Mulkey, Sarah B., DeBiasi, Roberta L., Biddle, Cara, Lee, Ellen H., Elmore, Amanda L., Scotland, Sarah J., Sowunmi, Similoluwa, Longcore, Nicole D., Ahmed, Muhammad, Langlois, Peter H., Khuwaja, Salma, Browne, Shea Elizabeth, Lind, Leah, Shim, Kyoo, Gosciminski, Michael, Blumenfeld, Rachel, Khuntia, Shreya, Halai, Umme-Aiman, Locklear, Autumn, Chan, Mary, Willabus, Teri’, Tonzel, Julius, Marzec, Natalie S., Barreto, Nianest Alers, Sanchez, Connie, Fornoff, Jane, Hale, Shelby, Nance, Amy, Iguchi, Lisa, Adibhatla, Sowmya N., Potts, Emily, Schiffman, Elizabeth, Raman, Devin, McDonald, Morgan F., Stricklin, Brandi, Ludwig, Elizabeth, Denson, Lindsay, Contreras, Dianna, Romitti, Paul A., Ferrell, Emily, Marx, Meghan, Signs, Kimberly, Cook, Amie, Leedom, Vinita Oberoi, Beauregard, Suzann, Orantes, Lucia C., Cronquist, Laura, Roush, Lesley, Godfred-Cato, Shana, Gilboa, Suzanne M., Meaney-Delman, Dana, Honein, Margaret A., Moore, Cynthia A., and Tong, Van T.

Published
2024
Full Text
View/download PDF

4. Preterm birth among pregnant persons with severe acute respiratory syndrome Coronavirus 2 infection

Author

Newton, Suzanne M., Reeves, Emily L., O’Malley Olsen, Emily, Woodworth, Kate R., Farr, Sherry L., Galang, Romeo R., Reynolds, Megan R., Harvey, Elizabeth, Shi, Jing, Nestoridi, Eirini, Barton, Jerusha, Ngo, Van P., Lush, Mamie, Longcore, Nicole D., Dzimira, Paula, Im, Lucille K., Sokale, Ayomide, Siebman, Samantha, Delgado López, Camille, Chen, Tiffany, Mobley, Evan L., Khuwaja, Salma, Romitti, Paul A., Fredette, Carolyn, Ellis, Esther M., Silcox, Kristin, Hall, Aron J., Azziz-Baumgartner, Eduardo, Gilboa, Suzanne M., Shapiro-Mendoza, Carrie K., and Tong, Van T.

Published
2022
Full Text
View/download PDF

5. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020

Author

CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, Woodworth, Kate R., Olsen, Emily O’Malley, Neelam, Varsha, Lewis, Elizabeth L., Galang, Romeo R., Oduyebo, Titilope, Aveni, Kathryn, Yazdy, Mahsa M., Harvey, Elizabeth, Longcore, Nicole D., Barton, Jerusha, Fussman, Chris, Siebman, Samantha, Lush, Mamie, Patrick, Paul H., Halai, Umme-Aiman, Valencia-Prado, Miguel, Orkis, Lauren, Sowunmi, Similoluwa, Schlosser, Levi, Khuwaja, Salma, Read, Jennifer S., Hall, Aron J., Meaney-Delman, Dana, Ellington, Sascha R., Gilboa, Suzanne M., and Tong, Van T.

Published
2020

6. Outcomes up to age 36 months after congenital Zika virus infection—U.S. states

Author

Neelam, Varsha, primary, Woodworth, Kate R., additional, Chang, Daniel J., additional, Roth, Nicole M., additional, Reynolds, Megan R., additional, Akosa, Amanda, additional, Carr, Christopher P., additional, Anderson, Kayla N., additional, Mulkey, Sarah B., additional, DeBiasi, Roberta L., additional, Biddle, Cara, additional, Lee, Ellen H., additional, Elmore, Amanda L., additional, Scotland, Sarah J., additional, Sowunmi, Similoluwa, additional, Longcore, Nicole D., additional, Ahmed, Muhammad, additional, Langlois, Peter H., additional, Khuwaja, Salma, additional, Browne, Shea Elizabeth, additional, Lind, Leah, additional, Shim, Kyoo, additional, Gosciminski, Michael, additional, Blumenfeld, Rachel, additional, Khuntia, Shreya, additional, Halai, Umme-Aiman, additional, Locklear, Autumn, additional, Chan, Mary, additional, Willabus, Teri’, additional, Tonzel, Julius, additional, Marzec, Natalie S., additional, Barreto, Nianest Alers, additional, Sanchez, Connie, additional, Fornoff, Jane, additional, Hale, Shelby, additional, Nance, Amy, additional, Iguchi, Lisa, additional, Adibhatla, Sowmya N., additional, Potts, Emily, additional, Schiffman, Elizabeth, additional, Raman, Devin, additional, McDonald, Morgan F., additional, Stricklin, Brandi, additional, Ludwig, Elizabeth, additional, Denson, Lindsay, additional, Contreras, Dianna, additional, Romitti, Paul A., additional, Ferrell, Emily, additional, Marx, Meghan, additional, Signs, Kimberly, additional, Cook, Amie, additional, Leedom, Vinita Oberoi, additional, Beauregard, Suzann, additional, Orantes, Lucia C., additional, Cronquist, Laura, additional, Roush, Lesley, additional, Godfred-Cato, Shana, additional, Gilboa, Suzanne M., additional, Meaney-Delman, Dana, additional, Honein, Margaret A., additional, Moore, Cynthia A., additional, and Tong, Van T., additional

Published
2023
Full Text
View/download PDF

7. Pre-exposure Prophylaxis Use and Detected Sexually Transmitted Infections Among Men Who Have Sex With Men in the United States—National HIV Behavioral Surveillance, 5 US Cities, 2017

Author

Chapin-Bardales, Johanna, Johnson Jones, Michelle L., Kirkcaldy, Robert D., Bernstein, Kyle T., Paz-Bailey, Gabriela, Phillips, Christi, Papp, John R., Raymond, Henry F., Opoku, Jenevieve, Braunstein, Sarah L., Spencer, Emma C., Khuwaja, Salma, and Wejnert, Cyprian

Published
2020
Full Text
View/download PDF

9. Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas: Insights From a Modeling Study.

Author

Lee, Francis, Lee, Francis, Khanna, Aditya S, Hallmark, Camden J, Lavingia, Richa, McNeese, Marlene, Zhao, Jing, McNeese, Melanie L, Khuwaja, Salma, Ardestani, Babak M, Collier, Nicholson, Ozik, Jonathan, Hotton, Anna L, Harawa, Nina T, Schneider, John A, Fujimoto, Kayo, Lee, Francis, Lee, Francis, Khanna, Aditya S, Hallmark, Camden J, Lavingia, Richa, McNeese, Marlene, Zhao, Jing, McNeese, Melanie L, Khuwaja, Salma, Ardestani, Babak M, Collier, Nicholson, Ozik, Jonathan, Hotton, Anna L, Harawa, Nina T, Schneider, John A, and Fujimoto, Kayo

Abstract

ContextMedicaid expansion has been nationally shown to improve engagement in the human immunodeficiency virus (HIV) treatment and prevention continua, which are vital steps to stopping the HIV epidemic. New HIV infections in the United States are disproportionately concentrated among young Black men who have sex with men (YBMSM). Houston, TX, is the most populous city in the Southern United States with a racially/ethnically diverse population that is located in 1 of 11 US states that have not yet expanded Medicaid coverage as of 2021.MethodsAn agent-based model that incorporated the sexual networks of YBMSM was used to simulate improved antiretroviral treatment and pre-exposure prophylaxis (PrEP) engagement through Medicaid expansion in Houston, TX. Analyses considered the HIV incidence (number of new infections and as a rate metric) among YBMSM over the next 10 years under Medicaid expansion as the primary outcome. Additional scenarios, involving viral suppression and PrEP uptake above the projected levels achieved under Medicaid expansion, were also simulated.ResultsThe baseline model projected an HIV incidence rate of 4.96 per 100 person years (py) and about 368 new annual HIV infections in the 10th year. Improved HIV treatment and prevention continua engagement under Medicaid expansion resulted in a 14.9% decline in the number of annual new HIV infections in the 10th year. Increasing viral suppression by an additional 15% and PrEP uptake by 30% resulted in a 44.0% decline in new HIV infections in the 10th year, and a 27.1% decline in cumulative infections across the 10 years of the simulated intervention.FindingsSimulation results indicate that Medicaid expansion has the potential to reduce HIV incidence among YBMSM in Houston. Achieving HIV elimination objectives, however, might require additional effective measures to increase antiretroviral treatment and PrEP uptake beyond the projected improvements under expanded Medicaid.

Published
2023

10. Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas

Author

Lee, Francis, primary, Khanna, Aditya S., additional, Hallmark, Camden J., additional, Lavingia, Richa, additional, McNeese, Marlene, additional, Zhao, Jing, additional, McNeese, Melanie L., additional, Khuwaja, Salma, additional, Ardestani, Babak M., additional, Collier, Nicholson, additional, Ozik, Jonathan, additional, Hotton, Anna L., additional, Harawa, Nina T., additional, Schneider, John A., additional, and Fujimoto, Kayo, additional

Published
2022
Full Text
View/download PDF

11. Six-Month Outcomes of Infants Born to People With SARS-CoV-2 in Pregnancy

Author

Gosdin, Lucas, primary, Wallace, Bailey, additional, Lanzieri, Tatiana M., additional, Olsen, Emily O’Malley, additional, Lewis, Elizabeth L., additional, Chang, Daniel J., additional, Khuwaja, Salma, additional, Chicchelly, Sarah, additional, Ojo, Kristen D., additional, Lush, Mamie, additional, Heitner, Daniel, additional, Longcore, Nicole D., additional, Delgado-López, Camille, additional, Humphries, Brian K., additional, Sizemore, Lindsey, additional, Mbotha, Deborah, additional, Hall, Aron J., additional, Ellington, Sascha, additional, Gilboa, Suzanne M., additional, Tong, Van T., additional, and Woodworth, Kate, additional

Published
2022
Full Text
View/download PDF

14. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020

Author

Woodworth, Kate R., Olsen, Emily O’Malley, Neelam, Varsha, Lewis, Elizabeth L., Galang, Romeo R., Oduyebo, Titilope, Aveni, Kathryn, Yazdy, Mahsa M., Harvey, Elizabeth, Longcore, Nicole D., Barton, Jerusha, Fussman, Chris, Siebman, Samantha, Lush, Mamie, Patrick, Paul H., Halai, Umme-Aiman, Valencia-Prado, Miguel, Orkis, Lauren, Sowunmi, Similoluwa, Schlosser, Levi, Khuwaja, Salma, Read, Jennifer S., Hall, Aron J., Meaney-Delman, Dana, Ellington, Sascha R., Gilboa, Suzanne M., Tong, Van T., Delaney, Augustina, Hsia, Jason, King, Kellianne, Perez, Mirna, Reynolds, Megan, Riser, Aspen, Rivera, Maria, Sancken, Christina, Sims, John, Smoots, Ashley, Snead, Margaret, Strid, Penelope, Yowe-Conley, Tineka, Zambrano, Laura, Zapata, Lauren, Manning, Susan, Burkel, Veronica, Akosa, Amanda, Bennett, Carolyne, Griffin, Isabel, Nahabedian, John, Newton, Suzanne, Roth, Nicole M., Shinde, Neha, Whitehouse, Erin, Chang, Daniel, Fox, Charise, Mohamoud, Yousra, and Whitehill, Florence

Subjects
Health (social science), Epidemiology, Health, Toxicology and Mutagenesis, Abortion, 01 natural sciences, 0302 clinical medicine, COVID-19 Testing, Health Information Management, Pregnancy, Infection control, 030212 general & internal medicine, Full Report, Young adult, Pregnancy Complications, Infectious, education.field_of_study, Obstetrics, Pregnancy Outcome, Gestational age, General Medicine, Premature birth, Premature Birth, Female, Coronavirus Infections, Adult, medicine.medical_specialty, Population, Pneumonia, Viral, Risk Assessment, 03 medical and health sciences, Betacoronavirus, Young Adult, medicine, Humans, 0101 mathematics, education, Pandemics, business.industry, Clinical Laboratory Techniques, SARS-CoV-2, Public health, 010102 general mathematics, Infant, Newborn, COVID-19, medicine.disease, Infectious Disease Transmission, Vertical, United States, Abortion, Spontaneous, business, Laboratories
Abstract

Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness and might be at risk for preterm birth (1-3). The full impact of infection with SARS-CoV-2, the virus that causes COVID-19, in pregnancy is unknown. Public health jurisdictions report information, including pregnancy status, on confirmed and probable COVID-19 cases to CDC through the National Notifiable Diseases Surveillance System.* Through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), 16 jurisdictions collected supplementary information on pregnancy and infant outcomes among 5,252 women with laboratory-confirmed SARS-CoV-2 infection reported during March 29-October 14, 2020. Among 3,912 live births with known gestational age, 12.9% were preterm (

Published
2020

16. SARS‐CoV‐2 infections among neonates born to pregnant people with SARS‐CoV‐2 infection: Maternal, pregnancy and birth characteristics

Author

Olsen, Emily O'Malley, primary, Roth, Nicole M., additional, Aveni, Kathryn, additional, Santos, Pauline, additional, Sizemore, Lindsey, additional, Halai, Umme‐Aiman, additional, Nestoridi, Eirini, additional, Barton, Jerusha Elana, additional, Mobley, Evan, additional, Siebman, Samantha, additional, Fussman, Chris, additional, Mbotha, Deborah, additional, Dzimira, Paula, additional, Silcox, Kristin M., additional, Khuwaja, Salma, additional, Roscom, Danacamile, additional, Lush, Mamie, additional, Chicchelly, Sarah, additional, Delgado‐López, Camille, additional, Schlosser, Levi, additional, Read, Jennifer, additional, Ellington, Sascha R., additional, Hall, Aron J., additional, Gilboa, Suzanne M., additional, Tong, Van T., additional, and Woodworth, Kate R., additional

Published
2022
Full Text
View/download PDF

17. Preterm Birth among Pregnant Persons with Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Author

Newton, Suzanne M., primary, Reeves, Emily L., additional, Olsen, Emily O'Malley, additional, Woodworth, Kate, additional, Farr, Sherry L., additional, Galang, Romeo R., additional, Reynolds, Megan R., additional, Harvey, Elizabeth, additional, Shi, Jing, additional, Nestoridi, Eirini, additional, Barton, Jerusha, additional, Ngo, Van P., additional, Lush, Mamie, additional, Longcore, Nicole D., additional, Dzimira, Paula, additional, Im, Lucille K., additional, Sokale, Ayomide, additional, Siebman, Samantha, additional, Lopez, Camille Delgado, additional, Chen, Tiffany, additional, Nyquist-Smith, Natasha, additional, Mobley, Evan L., additional, Khuwaja, Salma, additional, Romitti, Paul A., additional, Fredette, Carolyn, additional, Ellis, Esther M., additional, Silcox, Kristin, additional, Hall, Aron J., additional, Azziz-Baumgartner, Eduardo, additional, Gilboa, Suzanne M., additional, Shapiro-Mendoza, Carrie K., additional, and Tong, Van T., additional

Published
2022
Full Text
View/download PDF

18. Zika-Associated Birth Defects Reported in Pregnancies with Laboratory Evidence of Confirmed or Possible Zika Virus Infection — U.S. Zika Pregnancy and Infant Registry, December 1, 2015–March 31, 2018

Author

Roth, Nicole M., primary, Reynolds, Megan R., additional, Lewis, Elizabeth L., additional, Woodworth, Kate R., additional, Godfred-Cato, Shana, additional, Delaney, Augustina, additional, Akosa, Amanda, additional, Valencia-Prado, Miguel, additional, Lash, Maura, additional, Elmore, Amanda, additional, Langlois, Peter, additional, Khuwaja, Salma, additional, Tufa, Aifili, additional, Ellis, Esther M., additional, Nestoridi, Eirini, additional, Lyu, Caleb, additional, Longcore, Nicole D, additional, Piccardi, Monika, additional, Lind, Leah, additional, Starr, Sharon, additional, Johnson, Loletha, additional, Browne, Shea E., additional, Gosciminski, Michael, additional, Velasco, Paz E., additional, Johnson-Clarke, Fern, additional, Locklear, Autumn, additional, Chan, Mary, additional, Fornoff, Jane, additional, Toews, Karrie-Ann E., additional, Tonzel, Julius, additional, Marzec, Natalie S., additional, Hale, Shelby, additional, Nance, Amy E., additional, Willabus, Teri, additional, Contreras, Dianna, additional, Adibhatla, Sowmya N., additional, Iguchi, Lisa, additional, Potts, Emily, additional, Schiffman, Elizabeth, additional, Lolley, Katherine, additional, Stricklin, Brandi, additional, Ludwig, Elizabeth, additional, Garstang, Helentina, additional, Marx, Meghan, additional, Ferrell, Emily, additional, Moreno-Gorrin, Camille, additional, Signs, Kimberly, additional, Romitti, Paul, additional, Leedom, Vinita, additional, Martin, Brennan, additional, Castrodale, Louisa, additional, Cook, Amie, additional, Fredette, Carolyn, additional, Denson, Lindsay, additional, Cronquist, Laura, additional, Nahabedian, John F., additional, Shinde, Neha, additional, Polen, Kara, additional, Gilboa, Suzanne M., additional, Martin, Stacey W., additional, Cragan, Janet D., additional, Meaney-Delman, Dana, additional, Honein, Margaret A., additional, Tong, Van T., additional, and Moore, Cynthia A., additional

Published
2022
Full Text
View/download PDF

19. Racial/Ethnic Disparities in HIV Preexposure Prophylaxis Among Men Who Have Sex with Men — 23 Urban Areas, 2017

Author

Kanny, Dafna, Jeffries, William L., Chapin-Bardales, Johanna, Denning, Paul, Cha, Susan, Finlayson, Teresa, Wejnert, Cyprian, Abrego, Meaghan, Al-Tayyib, Alia, Anderson, Bridget, Barak, Narquis, Beckford, Jeremy M., Bolden, Barbara, Brady, Kathleen A., Brandt, Mary-Grace, Brantley, Meredith, Braunstein, Sarah, Buyu, Celestine, Cano, Rosalinda, Carrillo, Sidney, Deng, Jie, Diepstra, Karen, Doherty, Rose, Flynn, Anna, Flynn, Colin, Forrest, David, German, Danielle, Glick, Sara, Godette, Henry, Griffin, Vivian, Higgins, Emily, Ick, Theresa, Jaenicke, Tom, Jimenez, Antonio D., Khuwaja, Salma, Klevens, Monina, Kuo, Irene, Lopez, Zaida, Ma, Yingbo, Masiello Schuette, Stephanie, Mattson, Melanie, McGoy, Shanell L., Melton, David, Miranda De León, Sandra, Nixon, Willie, Nnumolu, Chrysanthus, O’Cleirigh, Conall, Opoku, Jenevieve, Orellana, E. Roberto, Padgett, Paige, Poe, Jonathon, Raymond, H. Fisher, Reid, Toyah, Rivera, Alexis, Robinson, William T., Rolón-Colón, Yadira, Rosack, Randi, Schafer, Sean, Sey, Ekow Kwa, Shinefeld, Jennifer, Spencer, Emma, Tate, Ashley, Todd, Jeff, Vaaler, Margaret, Wogayehu, Afework, and Wortley, Pascale

Subjects
Adult, Male, Health Knowledge, Attitudes, Practice, Health (social science), Adolescent, Urban Population, Epidemiology, Health, Toxicology and Mutagenesis, media_common.quotation_subject, Ethnic group, Human immunodeficiency virus (HIV), HIV Infections, medicine.disease_cause, White People, Men who have sex with men, Young Adult, 03 medical and health sciences, Pre-exposure prophylaxis, 0302 clinical medicine, Health Information Management, immune system diseases, 030225 pediatrics, Humans, Medicine, Full Report, 030212 general & internal medicine, Homosexuality, Healthcare Disparities, Homosexuality, Male, Young adult, reproductive and urinary physiology, media_common, business.industry, Hiv incidence, virus diseases, Hispanic or Latino, General Medicine, Middle Aged, United States, Racial ethnic, Black or African American, Pre-Exposure Prophylaxis, business, Demography
Abstract

In 2017, preliminary data show that gay, bisexual, and other men who have sex with men (MSM) accounted for 67% of new diagnoses of human immunodeficiency virus (HIV) infection, that MSM who inject drugs accounted for an additional 3%, and that African American/black (black) and Hispanic/Latino (Hispanic) MSM were disproportionately affected (1). During 2010-2015, racial/ethnic disparities in HIV incidence increased among MSM; in 2015, rates among black and Hispanic MSM were 10.5 and 4.9 times as high, respectively, as the rate among white MSM (compared with 9.2 and 3.8 times as high, respectively, in 2010) (2). Increased use of preexposure prophylaxis (PrEP), which reduces the risk for sexual acquisition of HIV infection by approximately 99% when taken daily as prescribed,* would help to reduce these disparities and support the Ending the HIV Epidemic: A Plan for America initiative† (3). Although PrEP use has increased among all MSM since 2014 (4), racial/ethnic disparities in PrEP use could increase existing disparities in HIV incidence among MSM (5). To understand racial/ethnic disparities in PrEP awareness, discussion with a health care provider, and use (steps in the HIV PrEP continuum of care) (6), CDC analyzed 2017 National HIV Behavioral Surveillance (NHBS) data. Black and Hispanic MSM were significantly less likely than were white MSM to be aware of PrEP, to have discussed PrEP with a health care provider, or to have used PrEP within the past year. Among those who had discussed PrEP with a health care provider within the past year, 68% of white MSM, 62% of Hispanic MSM, and 55% of black MSM, reported PrEP use. Prevention efforts need to increase PrEP use among all MSM and target eliminating racial/ethnic disparities in PrEP use.§.

Published
2019
Full Text
View/download PDF

20. Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men — 20 Urban Areas, 2014 and 2017

Author

Finlayson, Teresa, Cha, Susan, Xia, Ming, Trujillo, Lindsay, Denson, Damian, Prejean, Joseph, Kanny, Dafna, Wejnert, Cyprian, Abrego, Meaghan, Al-Tayyib, Alia, Anderson, Bridget, Barak, Narquis, Bayang, Lissa, Beckford, Jeremy M., Benbow, Nanette, Bolden, Barbara, Brady, Kathleen A., Brandt, Mary-Grace, Braunstein, Sarah, Burt, Richard, Cano, Rosalinda, Carrillo, Sidney, Deng, Jie, Doherty, Rose, Flynn, Anna, Flynn, Colin, Forrest, David, Fukuda, Dawn, German, Danielle, Glick, Sara, Godette, Henry, Griffin, Vivian, Higgins, Emily, Ick, Theresa, Jaenicke, Tom, Jimenez, Antonio D., Khuwaja, Salma, Klevens, Monina, Kuo, Irene, LaLota, Marlene, Lopez, Zaida, Ma, Yingbo, Macomber, Kathryn, Masiello Schuette, Stephanie, Mattson, Melanie, Melton, David, Miranda De León, Sandra, Neaigus, Alan, Nixon, Willie, Nnumolu, Chrysanthus, Novoa, Alicia, O’Cleirigh, Conall, Opoku, Jenevieve, Padgett, Paige, Poe, Jonathon, Prachand, Nikhil, Raymond, H. Fisher, Rehman, Hafeez, Reilly, Kathleen H., Rivera, Alexis, Robinson, William T., Rolón-Colón, Yadira, Sato, Kimi, Schacht, John-Mark, Sey, Ekow Kwa, Sheu, Shane, Shinefeld, Jennifer, Shpaner, Mark, Sinclair, Amber, Smith, Lou, Spencer, Emma, Tate, Ashley, Thiede, Hanne, Todd, Jeff, Tovar-Moore, Veronica, Vaaler, Margaret, Wittke, Chris, Wogayehu, Afework, Wortley, Pascale, and Zarwell, Meagan C.

Subjects
Adult, Male, Health Knowledge, Attitudes, Practice, Health (social science), Adolescent, Urban Population, Epidemiology, Health, Toxicology and Mutagenesis, media_common.quotation_subject, MEDLINE, HIV Infections, 01 natural sciences, Men who have sex with men, Young Adult, 03 medical and health sciences, Pre-exposure prophylaxis, 0302 clinical medicine, Health Information Management, Environmental health, Health care, Humans, Medicine, Full Report, 030212 general & internal medicine, Homosexuality, Homosexuality, Male, 0101 mathematics, Young adult, Epidemics, Human services, media_common, business.industry, 010102 general mathematics, virus diseases, Hispanic or Latino, General Medicine, United States, Black or African American, Pre-Exposure Prophylaxis, Rural area, business
Abstract

In February 2019, the U.S. Department of Health and Human Services proposed a strategic initiative to end the human immunodeficiency (HIV) epidemic in the United States by reducing new HIV infections by 90% during 2020-2030* (1). Phase 1 of the Ending the HIV Epidemic initiative focuses on Washington, DC; San Juan, Puerto Rico; and 48 counties where the majority of new diagnoses of HIV infection in 2016 and 2017 were concentrated and on seven states with a disproportionate occurrence of HIV in rural areas relative to other states.† One of the four pillars in the initiative is protecting persons at risk for HIV infection using proven, comprehensive prevention approaches and treatments, such as HIV preexposure prophylaxis (PrEP), which is the use of antiretroviral medications that have proven effective at preventing infection among persons at risk for acquiring HIV. In 2014, CDC released clinical PrEP guidelines to health care providers (2) and intensified efforts to raise awareness and increase the use of PrEP among persons at risk for infection, including gay, bisexual, and other men who have sex with men (MSM), a group that accounted for an estimated 68% of new HIV infections in 2016 (3). Data from CDC's National HIV Behavioral Surveillance (NHBS) were collected in 20 U.S. urban areas in 2014 and 2017, covering 26 of the geographic areas included in Phase I of the Ending the HIV Epidemic initiative, and were compared to assess changes in PrEP awareness and use among MSM. From 2014 to 2017, PrEP awareness increased by 50% overall, with >80% of MSM in 17 of the 20 urban areas reporting PrEP awareness in 2017. Among MSM with likely indications for PrEP (e.g., sexual risk behaviors or recent bacterial sexually transmitted infection [STI]), use of PrEP increased by approximately 500% from 6% to 35%, with significant increases observed in all urban areas and in almost all demographic subgroups. Despite this progress, PrEP use among MSM, especially among black and Hispanic MSM, remains low. Continued efforts to improve coverage are needed to reach the goal of 90% reduction in HIV incidence by 2030. In addition to developing new ways of connecting black and Hispanic MSM to health care providers through demonstration projects, CDC has developed resources and tools such as the Prescribe HIV Prevention program to enable health care providers to integrate PrEP into their clinical care.§ By routinely testing their patients for HIV, assessing HIV-negative patients for risk behaviors, and prescribing PrEP as needed, health care providers can play a critical role in this effort.

Published
2019
Full Text
View/download PDF

21. Extragenital Chlamydia and Gonorrhea Among Community Venue–Attending Men Who Have Sex with Men — Five Cities, United States, 2017

Author

Johnson Jones, Michelle L., Chapin-Bardales, Johanna, Bizune, Destani, Papp, John R., Phillips, Christi, Kirkcaldy, Robert D., Wejnert, Cyprian, Bernstein, Kyle T., Khuwaja, Salma, Lopez, Zaida, Padgett, Paige, Forrest, David, Nixon, Willie, Spencer, Emma, Braunstein, Sarah, Carrillo, Sidney, Rivera, Alexis, Ick, Theresa, Raymond, H. Fisher, Opoku, Jenevieve, and Kuo, Irene

Subjects
Adult, Male, medicine.medical_specialty, Health (social science), Adolescent, Epidemiology, Health, Toxicology and Mutagenesis, media_common.quotation_subject, Gonorrhea, Prevalence, urologic and male genital diseases, 01 natural sciences, Men who have sex with men, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Health Information Management, medicine, Humans, Full Report, Community Health Services, 030212 general & internal medicine, Homosexuality, Cities, Homosexuality, Male, 0101 mathematics, Young adult, media_common, Chlamydia, Transmission (medicine), business.industry, 010102 general mathematics, virus diseases, General Medicine, Chlamydia Infections, Middle Aged, medicine.disease, United States, female genital diseases and pregnancy complications, business, Demography
Abstract

Sexually transmitted diseases (STDs) disproportionately affect gay, bisexual, and other men who have sex with men (MSM) in the United States (1). Because chlamydia and gonorrhea at extragenital (rectal and pharyngeal) anatomic sites are often asymptomatic, these anatomic sites serve as a reservoir of infection, which might contribute to gonococcal antimicrobial resistance (2) and increased risk for human immunodeficiency virus (HIV) transmission and acquisition (3). To ascertain prevalence of extragenital STDs, MSM attending community venues were recruited in five U.S. cities to provide self-collected swabs for chlamydia and gonorrhea screening as part of National HIV Behavioral Surveillance (NHBS). Overall, 2,075 MSM provided specimens with valid results, and 13.3% of participants were infected with at least one of the two pathogens in at least one of these two extragenital anatomic sites. Approximately one third of participating MSM had not been screened for STDs in the previous 12 months. MSM attending community venues had a high prevalence of asymptomatic extragenital STDs. The findings underscore the importance of sexually active MSM following current recommendations for STD screening at all exposed anatomic sites at least annually (4).

Published
2019
Full Text
View/download PDF

23. SARS-CoV-2 infections among neonates born to women with SARS-CoV-2 infection: maternal, pregnancy and birth characteristics

Author

Olsen, Emily O’Malley, primary, Roth, Nicole M., additional, Aveni, Kathryn, additional, Santos, Pauline, additional, Sizemore, Lindsey, additional, Halai, Umme-Aiman, additional, Nestoridi, Eirini, additional, Sowunmi, Similoluwa, additional, Barton, Jerusha Elana, additional, Mobley, Evan, additional, Siebman, Samantha, additional, Fussman, Chris, additional, Mbotha, Deborah, additional, Dzimira, Paula, additional, Silcox, Kristin M., additional, Khuwaja, Salma, additional, Roscom, Danacamile, additional, Lush, Mamie, additional, Chicchelly, Sarah, additional, Delgado-López, Camille, additional, Schlosser, Levi, additional, Read, Jennifer S., additional, Ellington, Sascha R., additional, Hall, Aron J., additional, Gilboa, Suzanne M., additional, Tong, Van T., additional, and Woodworth, Kate R., additional

Published
2021
Full Text
View/download PDF

34. Sources of clinical information used in HIV care and treatment: Are providers' choices related to their demographic and practice characteristics?

Author

Mgbere, Osaro, Khuwaja, Salma, Vigil, Karen J, Patel, Shital M, Wang, Jason, and Essien, Ekere James

Subjects
*AGE distribution, *ANALYSIS of variance, *ATTITUDE (Psychology), *CHI-squared test, *CLINICAL medicine, *CONFIDENCE intervals, *ETHNIC groups, *FISHER exact test, *HIV infections, *INFORMATION storage & retrieval systems, *MEDICAL databases, *MEDICAL care, *MEDICAL personnel, *PROFESSIONS, *RACE, *RESEARCH funding, *STATISTICAL sampling, *SEX distribution, *STATISTICS, *SURVEYS, *T-test (Statistics), *INFORMATION resources, *LOGISTIC regression analysis, *CROSS-sectional method, *DATA analysis software, *ODDS ratio
Abstract

HIV medical care providers need a wide range of evidence-based clinical information resources to manage their patients' health. We determined whether providers' choice of information sources for HIV care and treatment are associated with their demographic and medical practice characteristics. Data used for this study were obtained from a probability sample of HIV medical care providers in 13 outpatient HIV facilities in Houston/Harris County, Texas, surveyed between June and September 2009. The mean number of information sources used by HIV medical care providers for HIV care and treatment was 5.83 (95% confidence interval: 4.90–6.75). Antiretroviral therapy guidelines (95.6%), medical journals and textbooks (82.6%), and Internet sources (69.5%) were ranked first, second, and third as sources of clinical information. At least one of the providers' demographic or medical practice characteristics was significantly (p ⩽ 0.05) associated with six of the clinical information sources. Integration of these information resources into clinicians' workflow may enhance efficiency of HIV care and treatment and facilitate improved patients' care and health outcomes. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

38. Managing the Personal Side of Health Care among Patients with HIV/AIDS.

Author

Mgbere, Osaro, Khuwaja, Salma, Bell, Tanvir K., Rodriguez-Barradas, Maria C., Arafat, Raouf, Blair, Janet M., and Essien, Ekere James

Abstract

The study describes the HIV care providers' sociodemographic and medical practice characteristics and the health care services offered to patients during medical care encounters in Houston/Harris County, Texas. We used data from the pilot cycle of the Centers for Disease Control and Prevention Medical Monitoring Project Provider Survey conducted in June to September 2009. The average age and HIV care experience of the providers were 46.7 and 11.7 years, respectively, and they provided care to an average of 113 patients monthly. The average proportion of HIV-infected patients seen per month by race/ethnicity was 43.3% for blacks, 28.5% for whites, 26.6% for Hispanics, 1.3% for Asians, and 0.6% for other races. A total of 67% of providers offered HIV testing to all patients 13 to 64 years of age. Most HIV care providers (73.9%) reported that patients in their practices sought HIV care only after experiencing symptoms. Understanding the HIV care delivery system from providers' perspectives may help enhance support services, patients' ongoing care and retention, leading to improved health outcomes. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

44. Identification of Dengue Fever Cases in Houston, Texas, with Evidence of Autochthonous Transmission Between 2003 and 2005

Author

Murray, Kristy O., primary, Rodriguez, Liliana F., additional, Herrington, Emily, additional, Kharat, Vineetkumar, additional, Vasilakis, Nikolaos, additional, Walker, Christopher, additional, Turner, Cynthia, additional, Khuwaja, Salma, additional, Arafat, Raouf, additional, Weaver, Scott C., additional, Martinez, Diana, additional, Kilborn, Cindy, additional, Bueno, Rudy, additional, and Reyna, Martin, additional

Published
2013
Full Text
View/download PDF

45. Frequency and Determinants of Preventive Care Counseling by HIV Medical Care Providers during Encounters with Newly Diagnosed and Established HIV-Infected Patients.

Author

Mgbere, Osaro, Rodriguez-Barradas, Maria C., Bell, Tanvir K., Khuwaja, Salma, Arafat, Raouf, Essien, Ekere J., Singh, Mamta, Simmons, Paul, and Aguilar, Jonathan

Abstract

This study evaluates the frequency and determinants of preventive care counseling by HIV medical care providers (HMCPs) during encounters with newly diagnosed and established HIV-infected patients. Data used were from a probability sample of HMCPs in Houston/Harris County, Texas, surveyed in 2009. Overall, HMCPs offered more preventive care counseling to newly diagnosed than the established patients (adjusted odds ratio [AOR] = 7.28; 95% confidence interval [CI] = 2.86-16.80). They were more likely to counsel newly diagnosed patients than the established ones on medication and adherence (AOR = 14.70; 95% CI = 1.24-24.94), HIV risk reduction (AOR = 5.91; 95% CI = 0.48-7.13), and disease screening (AOR = 7.20; 95% CI = 0.72-11.81). HIV medical care providers who were less than 45 years of age, infectious disease specialists, and had less than 30 minutes of encounter time were less likely to counsel patients regardless of the status. Our findings suggest the need for HMCPs to improve their preventive care counseling efforts, in order to help patients build skills for adopting and maintaining safe behavior that could assist in reducing the risk of HIV transmission. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

48. System and Patient Barriers to Care among People Living with HIV/AIDS in Houston/Harris County, Texas: HIV Medical Care Providers' Perspectives.

Author

Mgbere, Osaro, Khuwaja, Salma, Bell, Tanvir K., Rodriguez-Barradas, Maria C., Arafat, Raouf, Essien, Ekere James, Singh, Mamta, Aguilar, Jonathan, and Roland, Eric

Abstract

In the United States, a considerable number of people diagnosed with HIV are not receiving HIV medical care due to some barriers. Using data from the Medical Monitoring Project survey of HIV medical care providers in Houston/Harris County, Texas, we assessed the HIV medical care providers' perspectives of the system and patient barriers to HIV care experienced by people living with HIV/AIDS (PLWHA). The study findings indicate that of the 14 HIV care barriers identified, only 1 system barrier and 7 patient barriers were considered of significant (P ≤ .05) importance, with the proportion of HIV medical care providers' agreement to these barriers ranging from 73.9% (cost of health care) to 100% (lack of social support systems and drug abuse problems). Providers' perception of important system and patient barriers varied significantly (P ≤ .05) by profession, race/ethnicity, and years of experience in HIV care. To improve access to and for consistent engagement in HIV care, effective intervention programs are needed to address the barriers identified especially in the context of the new health care delivery system. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

50. Houston, Texas (as of September 28, 2012), Confirmed and Probable Reported Cases.

Author

Khuwaja, Salma A.

Subjects
*DISEASES, *CLIMATOLOGY, *ENCEPHALITIS, *MENINGITIS
Abstract

The article focuses on offers information on some of the disease cases in Houston, Texas in relation to the state's climate. The author mentions that neuroinvasive diseases pertain to diseases that affect the nervous system such as encephalitis and meningitis. She states that non-neuroinvasive cases refer to cases that does not show neuroinvasion.

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results